Via VentureBeat
“’Our findings from the EHR analysis of COVID-19 progression can aid in a human pathophysiology enabled summary of the experimental therapies being investigated for COVID-19,’ concluded the coauthors. ‘A caveat of relying solely on [electronic medical record] inference is that mild phenotypes that may not lead to a presentation for clinical care, such as anosmia, may go unreported in otherwise asymptomatic patients. As at-home serology-based tests for COVID-19 with high sensitivity and specificity are approved, capturing these symptoms will become increasingly important in order to facilitate the continued development and refinement of disease models. EHR-integrated digital health tools may help address this need.'”
“The work was a part of the Mayo Clinic’s ongoing collaboration with Cambridge-based Nference, a participant in Mayo’s Clinical Data Analytics Platform program. Since January, Nference’s chief focus has been identifying targets and biomarkers for new drugs, matching patients with therapeutic regimens, and devising applications such as label expansion, postmarketing surveillance, and drug purposing.”
See more details on the nference’s findings from Mayo Clinic’s data from Venture Beat
MAA COVID-19 INFORMATION DISCLAIMER:
The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service. The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.
The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via email or other communications.
